rhodioloside has been researched along with Alveolitis, Fibrosing in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, X; Gao, L; He, H; Lin, H; Liu, J; Mao, J; Tang, H; Wu, T | 1 |
Bai, Y; Deng, F; Feng, J; Liang, L; Liu, X | 1 |
2 other study(ies) available for rhodioloside and Alveolitis, Fibrosing
Article | Year |
---|---|
Salidroside protects against bleomycin-induced pulmonary fibrosis: activation of Nrf2-antioxidant signaling, and inhibition of NF-κB and TGF-β1/Smad-2/-3 pathways.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Bleomycin; Cell Line; Glucosides; Humans; Lung; NF-E2-Related Factor 2; NF-kappa B; Phenols; Pulmonary Fibrosis; Rats, Sprague-Dawley; Rhodiola; Signal Transduction; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta1 | 2016 |
[Salidroside improves pulmonary fibrosis by down-regulation of cathepsin B and NF-κBp65 in rats].
Topics: Animals; Cathepsin B; Down-Regulation; Glucosides; Lung; NF-kappa B; Oximetry; Oxygen; Phenols; Pulmonary Fibrosis; Pulmonary Gas Exchange; Pyridones; Rats; Rats, Sprague-Dawley | 2017 |